References
Nishi M, Kajisa T, Akune T, et al. Cardia cancer — proposal of cancer in the esophagogastric junction (in Japanese). Geka Shinryo (Surgical Diagnosis and Treatment) 1973; 15: 1328–1338.
Siewert JR, Stein HJ. Carcinoma of the cardia: carcinoma of the gastroesophageal junction — classification, pathology and extent of resection. Dis Esophagus 1996; 9: 173–182.
Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma (in Japanese). 13th ed. Kanehara Shuppan, Tokyo, 1999; 39.
References
Japan Society for Head and Neck Cancer. General Rules for Clinical Studies on Head and Neck Cancer (in Japanese). 4th ed. Kanehara Shuppan, Tokyo, 2005.
Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma (in Japanese). 13th ed. Kanehara Shuppan, Tokyo, 1999.
Reference
Fujita H, Sueyoshi S, Tanaka T, et al. A new N category for cancer of the cervical esophagus based on lymph node compartments. Esophagus 2008; 5: 19–26.
Reference
Fujita H, Aikou T, Tsurumaru M, et al. A new N category for cancer in the esophagogastric junction based on lymph node compartments. Esophagus 2007; 4: 103–110.
References
Schlemper RJ, Dawsey SM, Itabashi M, et al. Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer 2000; 88: 996–1006.
Schlemper RJ, Riddell RH, Kato, Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251–255.
Gabbert HE, Shimoda T, Hainaut P, et al. Squamous cell carcinoma of the esophagus. WHO Classification of Tumours. ed. Hamilton SR, Aaltonen LA, Pathology and Genetics of Tumours of the Digestive System. IARC Press, Lyon, 2000; 11–19.
Reference
Jaffe ES, Harris NL, Stein H, et al. WHO Classification of Tumors. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2001.
References
Fujimoto Y, Nakanishi Y, Yoshimura K, et al. Clinicopathological study of primary malignant gastrointestinal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer 2003; 6: 39–48.
Hasegawa T, Matsuno Y, Shimoda T, et al. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 2002; 33: 669–676.
Reference
Vakil N, Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidencebased consensus. Am J Gastroenterol 2006; 101: 1900–1920.
Reference
Japan Society for Cancer Therapy. General Rules for Reporting on Clinical Oncology-JSCT General Rules (in Japanese). Kanehara Shuppan, Tokyo, 1991; 10–34.
References
Therasse P, Arguck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000; 92: 205–216.
Tahara M, Ohtsu A, Hironaka S, et al. Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer. Jpn J Clin Oncol 2005; 35: 316–323.
Reference
Japanese Society for Esophageal Diseases. Guidelines for the Clinical and Pathological Studies on Carcinoma of the Esophagus (in Japanese). 9th ed. Kanehara Shuppan, Tokyo, 1999; 59–79.
Author information
Authors and Affiliations
Consortia
Additional information
These guidelines were published by Kanehara & CO., Ltd., Tokyo, copyright 2008 by Kanehara & CO., Ltd., and Japan Esophageal Society.
They are reprinted here by permission of the copyright holders.
Rights and permissions
About this article
Cite this article
Japan Esophageal Society. Japanese classification of esophageal cancer, tenth edition: parts II and III. Esophagus 6, 71–94 (2009). https://doi.org/10.1007/s10388-009-0193-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10388-009-0193-0